Microdose Bros presents an overview of the most significant psychedelic news stories from the week spanning October 30th to November 5th.
Promising Study Shows Psychedelic-Assisted Therapy Benefits
A recent clinical study revealed that psilocybin-assisted therapy has the potential to alleviate depression and anxiety in cancer patients. The findings indicate the positive impact of psychedelics in aiding mental health treatments.
Maryland Approves Psilocybin Research
Maryland became the latest state to authorize research into the therapeutic applications of psilocybin. This milestone highlights the growing recognition of psychedelics’ potential in addressing various mental health disorders.
Collaboration for Psychedelic Testing in Veterans
The Multidisciplinary Association for Psychedelic Studies (MAPS) announced a partnership with the US Department of Veterans Affairs to conduct clinical trials on MDMA-assisted therapy. This collaboration aims to explore methods of aiding veterans suffering from post-traumatic stress disorder (PTSD).
Solving Addiction; A Psychedelic Approach:
The University of Alabama will research the effectiveness of ibogaine, a psychedelic substance derived from African plants, in treating opioid addiction. This study offers hope for finding alternative therapies for individuals struggling with substance abuse.
Expanding Psilocybin Research in Oregon
Oregon Health & Science University received a $1.5 million grant to study the therapeutic potential of psilocybin. The university aims to look into the substance’s effects on patients with major depressive disorder, expanding the scope of psychedelic research.
Public Support for Psychedelic Therapy
A recent Ipsos poll indicated that 59% of Americans support the use of psychedelics in therapeutic settings. With growing public acceptance, the potential for psychedelic treatments to transform mental healthcare is gaining momentum.
In conclusion, exciting developments in psychedelic research and the recognition of their therapeutic potential continue to emerge. From breakthrough studies on psychedelics in cancer therapy to expanded research initiatives, these psychedelic news stories highlight the significant progress being made within the field.
